stroke

Details on surprise Novartis heart drug success due Aug 27
Details on surprise Novartis heart drug success due Aug 27
Yahoo/Reuters
Novartis
canakinumab
heart attacks
stroke
Flag link:
Why Amgen's Success Was a Big Disappointment
Why Amgen's Success Was a Big Disappointment
Motley Fool
Amgen
Repatha
heart attacks
stroke
Flag link:
Amgen Drug Prevents Heart Attacks, Not Deaths, Disappointing Experts
Amgen Drug Prevents Heart Attacks, Not Deaths, Disappointing Experts
Forbes
Amgen
Repatha
heart attacks
stroke
clinical trials
Flag link:
Amgen cholesterol drug cuts heart attack, stroke risk more than 20 pct-study
Amgen cholesterol drug cuts heart attack, stroke risk more than 20 pct-study
Yahoo/Reuters
Amgen
Repatha
heart attack
stroke
LDL cholesterol
Flag link:
Many at risk for stroke don’t get anti-clotting drugs
Many at risk for stroke don’t get anti-clotting drugs
Reuters
stroke
atrial fibrillation
Pradaxa
Xarelto
Eliquis
bloodthinners
Flag link:
Trial miss derails Acorda's Ampyra plans
Trial miss derails Acorda's Ampyra plans
BioPharma Dive
Acorda Therapeutics
AMPYRA
stroke
Flag link:
Acorda Stroke Study Fails, Dampening Revenue Growth Plans
Acorda Stroke Study Fails, Dampening Revenue Growth Plans
TheStreet.com
Acorda Therapeutics
AMPYRA
stroke
Flag link:
FDA approves St.Jude device to prevent recurring strokes in some patients
FDA approves St.Jude device to prevent recurring strokes in some patients
Yahoo/Reuters
FDA
St. Jude Medical
stroke
amplatzer PFO occluder
devices
Flag link:
Merck scraps development of osteoporosis drug due to stroke risk
Merck scraps development of osteoporosis drug due to stroke risk
Yahoo/Reuters
Merck
osteoporosis
stroke
Odanacatib
Flag link:
Nico touts studies using BrainPath to treat hemorrhagic stroke
Nico touts studies using BrainPath to treat hemorrhagic stroke
Mass Device
Nico
BrainPath
stroke
hemorrhagic stroke
devices
Flag link:
AstraZeneca heart drug fails in key stroke trial
AstraZeneca heart drug fails in key stroke trial
Yahoo/Reuters
AstraZeneca
stroke
clinical trials
Brilinta
Flag link:
J&J’s Biosense Webster buys Coherex Medical and its WaveCrest anti-stroke device
J&J’s Biosense Webster buys Coherex Medical and its WaveCrest anti-stroke device
Mass Device
JNJ
Biosense Webster
Coherex Medical
WaveCrest
stroke
devices
M&A
Flag link:
Eli Lilly's Diabetes Drug May Halt Heart Disease
Eli Lilly's Diabetes Drug May Halt Heart Disease
Motley Fool
Eli Lilly
Jardiance
stroke
diabetes
Boehringer Ingelheim
Flag link:
Boehringer says Pradaxa blood-thinning effect shown to be reversible
Boehringer says Pradaxa blood-thinning effect shown to be reversible
Yahoo/Reuters
Boehringer Ingelheim
Pradaxa
stroke
blood thinners
Flag link:
Athersys stroke treatment fails mid-stage study
Athersys stroke treatment fails mid-stage study
Yahoo/Reuters
Athersys
stroke
MultiStem
Flag link:
FDA OKs Silk Road Medical's anti-stroke Enroute device
FDA OKs Silk Road Medical's anti-stroke Enroute device
Mass Device
FDA
Silk Road Medical
stroke
devices
Enroute
Flag link:
Lundbeck pulls the plug on its fast-tracked stroke drug
Lundbeck pulls the plug on its fast-tracked stroke drug
Fierce Biotech
Lundbeck
stroke
desmoteplase
Flag link:
Researchers Report Thymosin Beta 4 Crosses Blood-Brain Barrier In Animal Stroke Model
Researchers Report Thymosin Beta 4 Crosses Blood-Brain Barrier In Animal Stroke Model
Yahoo/PR Newswire
Thymosin Beta 4
stroke
RegeneRx Biopharmaceuticals
Flag link:
Clot Busters For Stroke Gain More Support
Clot Busters For Stroke Gain More Support
Forbes
Activase
Roche
stroke
thrombolysis
Flag link:
FDA approves Zontivity to lower heart attack, stroke risk in high-risk patients
FDA approves Zontivity to lower heart attack, stroke risk in high-risk patients
The Fly on the Wall
stroke
heart attakc
Zontivity
Merck
FDA
Flag link: